139 related articles for article (PubMed ID: 33631225)
1. Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade.
Liu X; Feng Y; Xu J; Shi Y; Yang J; Zhang R; Song J; Bai X; Wu X; Bao Y; Luo Y; Li H; Chai L; Gong C; Wang Y; Chen B; Hu J; Fu Y; Luo Y; Zhang H; Shi H
J Control Release; 2021 Apr; 332():194-209. PubMed ID: 33631225
[TBL] [Abstract][Full Text] [Related]
2. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J
Front Immunol; 2023; 14():1279221. PubMed ID: 37942337
[TBL] [Abstract][Full Text] [Related]
3. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
4. Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem.
Song L; Zheng D; Xu J; Xu T; Liu Z; Zhang H; Li Y; Peng Y; Shi H
J Control Release; 2022 Nov; 351():954-969. PubMed ID: 36183970
[TBL] [Abstract][Full Text] [Related]
5. Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma.
Yu J; Wu X; Song J; Zhao Y; Li H; Luo M; Liu X
Front Pharmacol; 2022; 13():928226. PubMed ID: 36091815
[TBL] [Abstract][Full Text] [Related]
6. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy.
Zhao W; Hu X; Li W; Li R; Chen J; Zhou L; Qiang S; Wu W; Shi S; Dong C
Small; 2021 Apr; 17(13):e2007051. PubMed ID: 33599061
[TBL] [Abstract][Full Text] [Related]
7. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
8. Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity.
Xiang Q; Yang C; Luo Y; Liu F; Zheng J; Liu W; Ran H; Sun Y; Ren J; Wang Z
Small; 2022 Apr; 18(13):e2107809. PubMed ID: 35143709
[TBL] [Abstract][Full Text] [Related]
9. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment.
Wen Y; Chen X; Zhu X; Gong Y; Yuan G; Qin X; Liu J
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43393-43408. PubMed ID: 31701733
[TBL] [Abstract][Full Text] [Related]
10. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
[TBL] [Abstract][Full Text] [Related]
11. Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy.
Sun Z; Chu Y; Xiao J; Yang Y; Meng F; Wang X; Dong Y; Zhu J; Wu Y; Qin L; Ke Y; Liu B; Liu Q
J Transl Med; 2023 Sep; 21(1):619. PubMed ID: 37700338
[TBL] [Abstract][Full Text] [Related]
12. Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
Deken MA; Gadiot J; Jordanova ES; Lacroix R; van Gool M; Kroon P; Pineda C; Geukes Foppen MH; Scolyer R; Song JY; Verbrugge I; Hoeller C; Dummer R; Haanen JB; Long GV; Blank CU
Oncoimmunology; 2016; 5(12):e1238557. PubMed ID: 28123875
[TBL] [Abstract][Full Text] [Related]
13. Photothermal therapy mediated by gold nanocages composed of anti-PDL1 and galunisertib for improved synergistic immunotherapy in colorectal cancer.
Wang S; Song Y; Cao K; Zhang L; Fang X; Chen F; Feng S; Yan F
Acta Biomater; 2021 Oct; 134():621-632. PubMed ID: 34329782
[TBL] [Abstract][Full Text] [Related]
14. Microwave-triggered/HSP-targeted gold nano-system for triple-negative breast cancer photothermal therapy.
Cheng Y; Bao D; Chen X; Wu Y; Wei Y; Wu Z; Li F; Piao JG
Int J Pharm; 2021 Jan; 593():120162. PubMed ID: 33307159
[TBL] [Abstract][Full Text] [Related]
15. Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.
Jin L; Shen S; Huang Y; Li D; Yang X
Biomaterials; 2021 Jan; 268():120582. PubMed ID: 33302120
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
Zhang Y; Feng Y; Huang Y; Wang Y; Qiu L; Liu Y; Peng S; Li R; Kuang N; Shi Q; Shi Y; Chen Y; Joshi R; Wang Z; Yuan K; Min W
Front Immunol; 2020; 11():968. PubMed ID: 32582152
[No Abstract] [Full Text] [Related]
17. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
18. CXC Chemokine Receptor Type 4 Antagonistic Gold Nanorods Induce Specific Immune Responses and Long-Term Immune Memory to Combat Triple-Negative Breast Cancer.
Meng Y; Zhou J; Liu X; Zeng F; Wen T; Meng J; Liu J; Xu H
ACS Appl Mater Interfaces; 2023 Apr; 15(15):18734-18746. PubMed ID: 37017641
[TBL] [Abstract][Full Text] [Related]
19. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression.
Hwang HS; Cherukula K; Bang YJ; Vijayan V; Moon MJ; Thiruppathi J; Puth S; Jeong YY; Park IK; Lee SE; Rhee JH
Cells; 2020 Nov; 9(11):. PubMed ID: 33171765
[TBL] [Abstract][Full Text] [Related]
20. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy.
Huang L; Li Y; Du Y; Zhang Y; Wang X; Ding Y; Yang X; Meng F; Tu J; Luo L; Sun C
Nat Commun; 2019 Oct; 10(1):4871. PubMed ID: 31653838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
